4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-23-037394
Options or other derivatives
- Director acquired 20,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Heyman Richard A. Director | 2023-06-14 | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | D | ||
Loading xslF345X04/doc4.xml…